Takahashi Central Hospital, operated by the medical corporation Seiryokai, is located in Minamicho, Takahashi City, Okayama Prefecture, and serves as a community healthcare facility with a focus on internal medicine. The hospital actively incorporates state-of-the-art medical equipment, including the GE Healthcare bone densitometry system "PRODIGY Fuga C-Lite," which enables direct measurement of lumbar spine and femoral bone density using the DXA method. It also utilizes TBS (Trabecular Bone Score) software to assess the microstructural quality of bone, allowing for fracture risk evaluation beyond what conventional testing can detect. The hospital has also introduced the pocket-sized portable ultrasound device "Vscan air SL," enabling rapid diagnosis in a variety of settings such as emergency care and home visits. Since October 2024, the health screening center has offered "MySignal," a test that analyzes microRNA in urine to assess the risk of up to seven types of cancer, reflecting a strong commitment to early detection. In addition, the hospital provides private-pay options including cosmetic IV drip menus and PFC-FD therapy, demonstrating a willingness to address a wide range of medical needs. The hospital dispatched a DMAT team during the 2024 Noto Peninsula Earthquake and received a letter of appreciation from the Ministry of Health, Labour and Welfare for its contributions beyond the local community. The facility is fully barrier-free with wheelchair rentals available, offers services in English, and accepts credit cards and electronic payments. With ample parking on-site, it provides a highly accessible and convenient healthcare environment.
Dentistry
Dentistry
Dentistry
Dentistry
Dentistry
Dentistry